Literature DB >> 1584573

Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study.

B E Klein1, R Klein, K L Linton.   

Abstract

Age-related lens opacities are common and are a frequent cause of loss of vision. The Beaver Dam Eye Study was designed to estimate the prevalence and severity of lens opacities in a rural community in the United States. Adults between the ages of 43 and 84 years, identified by private census, were examined and participated in the study (n = 4926). Photographs were taken of the lenses and were graded in masked fashion according to a standardized protocol. For nuclear sclerosis, more severe levels occurred more commonly in older age groups and in women. Overall, 17.3% had nuclear sclerosis more severe than level 3 in a 5-step scale of severity. Cortical opacities increased with increasing age and were more common in women. They were found in 16.3% of the population. Posterior subcapsular opacities occur in 6.0% of the population. There was a significant trend of greater prevalence at older ages, but no sex effect. The frequency of early cataract increased in both sexes through the age group 65 to 74 years, but declined in those 75 years of age and older. The frequency of late cataract increased consistently with age. Women were more severely affected than men. This study confirms that lens opacities are common in adults in the United States. These data are important for providing for social and health care needs. It is important to determine causes of cataracts in order to develop preventive programs.

Entities:  

Mesh:

Year:  1992        PMID: 1584573     DOI: 10.1016/s0161-6420(92)31934-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  108 in total

1.  Purchasing good quality eye care: the provider's view.

Authors:  G Vafidis
Journal:  Qual Health Care       Date:  1997-06

2.  Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population.

Authors:  J T F Lau; V Lee; D Fan; M Lau; J Michon
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

3.  Mitochondrial proteomic analysis of isopsoralen protection against oxidative damage in human lens epithelial cells.

Authors:  Chun-Yan Feng; Xiu-Rong Huang; Ming-Xin Qi; Song-Wen Tang; Yan-Hong Hu; Sheng Chen; Fa-Jie Ke
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

4.  Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract.

Authors:  Andrea Hoffmann; Yusen Huang; Rinako Suetsugu-Maki; Carol S Ringelberg; Craig R Tomlinson; Katia Del Rio-Tsonis; Panagiotis A Tsonis
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Seeing into the future. Vision and aging.

Authors:  R E Kalina
Journal:  West J Med       Date:  1997-10

Review 6.  The epidemiology of age related eye diseases in Asia.

Authors:  T Y Wong; S-C Loon; S-M Saw
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

7.  Relation of ocular trauma to cortical, nuclear, and posterior subcapsular cataracts: the Beaver Dam Eye Study.

Authors:  T Y Wong; B E K Klein; R Klein; S C Tomany
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

8.  The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future.

Authors:  H Hashemi; A Yekta; E Jafarzadehpur; A Doostdar; H Ostadimoghaddam; M Khabazkhoob
Journal:  Eye (Lond)       Date:  2017-04-21       Impact factor: 3.775

9.  Views of older people on cataract surgery options: an assessment of preferences by conjoint analysis.

Authors:  M-A Ross; A J Avery; A J E Foss
Journal:  Qual Saf Health Care       Date:  2003-02

10.  Visual acuity outcomes after cataract extraction in adult latinos. The Los Angeles Latino Eye Study.

Authors:  Anne E Barañano; Joanne Wu; Kashif Mazhar; Stanley P Azen; Rohit Varma
Journal:  Ophthalmology       Date:  2007-09-12       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.